Artificial Intelligence (AI) In Respiratory Diseases Market Projected at $9.85 Billion by 2029 | Strategic Insights and Forecast Data
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Artificial Intelligence (AI) In Respiratory Diseases Market Size Changed, over the years?
The market size for artificial intelligence (AI) in respiratory diseases has seen substantial growth in the past few years. The market is projected to expand from $7.66 billion in 2024 to $8.05 billion in 2025, indicating a compound annual growth rate (CAGR) of 5.1%. Factors contributing to the historical growth include tightening government regulations, rising environmental concerns, an increasing older population, the evolution towards patient-focused healthcare practices and the escalation in healthcare infrastructure development.
How Much Will the Artificial Intelligence (AI) In Respiratory Diseases Market Be Worth in 2029?
In the coming years, the market for artificial intelligence (AI) in respiratory diseases is predicted to witness robust growth. The market is estimated to reach a value of $9.85 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.2%. Factors contributing to this growth during the forecast period include rising cases of respiratory diseases, the increasing demand for early detection and diagnosis, escalating environmental pollution, growing healthcare expenditures, as well as research and development efforts. The forecast period is also set to see major trends like technological advancements, drug discovery and development, personalization of treatment strategies, the advent of telemedicine and remote patient monitoring.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13792&type=smp
Which is the Largest Company in the Artificial Intelligence (AI) In Respiratory Diseases Market?
Major companies operating in the artificial intelligence (AI) in respiratory diseases market report are Siemens Healthineers, Philips Healthcare, General Electric (GE) Healthcare, Verily Life Sciences LLC, DeepMind Health, Merative L.P., Innovaccer, Freenome, Aidoc Medical, Butterfly Network, Infervision, Imagen Technologies, Caption Health, Gauss Surgical Inc., Swaasa AI, Inspirata Inc., VIDA Diagnostics Inc., Enlitic, Thirona B.v., ArtiQ, Icometrix, Zynnon AG, Aidence, Arterys, Dectrocel Healthcare, PneumoWave Ltd.
What Are the Main Market Drivers in the Artificial Intelligence (AI) In Respiratory Diseases Industry?
The escalation of environmental pollution is predicted to stimulate the expansion of artificial intelligence (AI) in the respiratory disease market. Environmental pollution involves introducing substances or energy to the environment at a pace that outstrips its safe dispersion or storage capacity. AI can potentially mitigate the adverse effects of environmental pollution on respiratory health through real-time surveillance, individualized risk evaluations, enlightened decision-making, and inventive solutions for people and communities. For example, the US Energy Information Administration, an American government entity, recorded that the CO2 emission in 2021 amounted to 35.72 billion metric tons and escalated to 38.50 billion metric tons in 2022 as recorded in June 2024. Consequently, the burgeoning environmental pollution is fostering the growth of artificial intelligence (AI) in the respiratory disease market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=13792&type=smp
How Is the Artificial Intelligence (AI) In Respiratory Diseases Market Segments Structured?
The artificial intelligence (AI) in respiratory diseases market covered in this report is segmented –
1) By Imaging Type: Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Electronic Patient-Reported Outcomes (ePRO)
2) By Indication: Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease, Pulmonary Infection
3) By End Use: Hospital, Diagnostic Centers, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Magnetic Resonance Imaging (MRI): Lung Imaging, Thoracic Imaging, Cardiopulmonary Imaging
2) By Computed Tomography (CT) Scan: High-Resolution CT (HRCT), Low-Dose CT, Thoracic CT
3) By Electronic Patient-Reported Outcomes (ePRO): Symptom Tracking, Medication Adherence Monitoring, Quality Of Life Assessments
What Strategic Trends Are Transforming the Artificial Intelligence (AI) In Respiratory Diseases Market?
Major firms in the respiratory diseases market that focus on artificial intelligence (AI) are introducing innovative solutions such as N-Tidal devices to track patients’ tidal breathing. The n-Tidal device gauges the amount of air exchanged during regular respiration, offering critical insights into lung activity. For example, in August 2023, TidalSense, a UK-based firm specializing in respiratory technology, launched N-Tidal, a regulated AI solution for diagnosing and managing chronic obstructive pulmonary disease (COPD). The tech merges N-Tidal’s CO2 sensor data with an AI platform to spot changes in lung activity, with the goal of enhancing COPD diagnosis and management. Clinical trials have shown this technology to be highly accurate, and it’s poised to revolutionize the diagnostic procedure for respiratory ailments. This introduction marks a crucial advancement in the application of AI for respiratory disease evaluation, providing a more efficient, pleasant alternative to present diagnostic procedures.
Access The Full Report Here:
Which Global Regions Offer the Highest Growth in the Artificial Intelligence (AI) In Respiratory Diseases Market?
North America was the largest region in the artificial Intelligence (AI) in respiratory diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in respiratory diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13792
This Report Delivers Insight On:
1. How big is the artificial intelligence (ai) in respiratory diseases market, and how is it changing globally?
2. Who are the major companies in the artificial intelligence (ai) in respiratory diseases market, and how are they performing?
3. What are the key opportunities and risks in the artificial intelligence (ai) in respiratory diseases market right now?
4. Which products or customer segments are growing the most in the artificial intelligence (ai) in respiratory diseases market?
5. What factors are helping or slowing down the growth of the artificial intelligence (ai) in respiratory diseases market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
